Leila Ghamkhar

No ORCID on file · 4 papers in corpus · active 2025-2026

Study types

  • other 4
other 2026
Journal of the American Geriatrics Society ·doi:10.1111/jgs.70379

BACKGROUND: Older adults are highly susceptible to adverse effects from potentially inappropriate medications (PIMs). Real-time clinical decision support systems (CDSS) may reduce unsafe prescribing; yet evidence from low- and middle-income…

other 2026
PloS one ·doi:10.1371/journal.pone.0345076

BACKGROUND: Drug-drug interactions (DDIs) represent a major preventable cause of medication-related harm globally. Their prevalence varies across health systems, but common drivers include polypharmacy, aging populations, and specialty-spec…

other 2025
Journal of infection and public health ·doi:10.1016/j.jiph.2025.102992

BACKGROUND: The financial and healthcare burden of hepatitis B and C remains a significant challenge in Iran, despite efforts to control these diseases through vaccination and improved treatment protocols. This study evaluates demographic a…

other 2025
Diabetes research and clinical practice ·doi:10.1016/j.diabres.2025.112078

INTRODUCTION: Diabetes mellitus (DM) is characterized by high blood glucose levels and abnormalities in metabolism. In 2021, 15.14% of adult Iranians had DM. The purpose of this study is to provide policymakers with actionable insights to e…